Insider · CIK 0001581383

FEKETE MICHAEL

Reports to the SEC for 2 companies · SCHAUMBURG, IL

sec.gov

Transactions

Companies

Filings

CIK

0001581383

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-01-05	SeaSpine Holdings CorpD Disposition to Issuer	Director	DDisposition to Issuer	−112K sh	—	—	0
2023-01-05	SeaSpine Holdings CorpStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−18.1K sh	—	—	0
2023-01-05	SeaSpine Holdings CorpStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,015 sh	—	—	0
2023-01-05	SeaSpine Holdings CorpStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−59.9K sh	—	—	0
2022-06-01	SeaSpine Holdings CorpA Award	Director	AAward	+7,653 sh	—	—	111,966
2022-06-01	SeaSpine Holdings CorpA Award	Director	AAward	+15.9K sh	—	—	104,313
2021-08-20	SeaSpine Holdings CorpP Purchase	Director	PPurchase	+10K sh	$14.80	+$148K	88,370
2021-06-02	SeaSpine Holdings CorpA Award	Director	AAward	+6,253 sh	—	—	75,369
2021-06-02	SeaSpine Holdings CorpA Award	Director	AAward	+3,001 sh	—	—	78,370
2020-06-03	SeaSpine Holdings CorpA Award	Director	AAward	+8,488 sh	—	—	63,598
2020-06-03	SeaSpine Holdings CorpA Award	Director	AAward	+5,518 sh	—	—	69,116
2019-05-29	SeaSpine Holdings CorpA Award	Director	AAward	+7,262 sh	—	—	55,110
2018-05-30	SeaSpine Holdings CorpA Award	Director	AAward	+5,757 sh	—	—	47,848
2018-05-30	SeaSpine Holdings CorpA Award	Director	AAward	+8,857 sh	—	—	42,091
2017-11-10	SeaSpine Holdings CorpP Purchase	Director	PPurchase	+930 sh	$10.25	+$9,532.5	33,234
2017-11-08	SeaSpine Holdings CorpP Purchase	Director	PPurchase	+560 sh	$10.25	+$5,740	32,304
2017-06-14	SeaSpine Holdings CorpA Award	Director	AAward	+16.6K sh	—	—	31,744
2017-03-15	SeaSpine Holdings CorpP Purchase	Director	PPurchase	+5,100 sh	$6.65	+$33.9K	15,110
2016-08-29	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−592 sh	$21.75	−$12.9K	0
2016-08-29	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−1,860 sh	$21.75	−$40.5K	0
2016-08-29	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−1,381 sh	$21.75	−$30K	0
2016-08-29	Sagent Pharmaceuticals, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−2,283 sh	$21.75	−$49.7K	2,041
2016-08-29	Sagent Pharmaceuticals, Inc.U Disposition from Tender	Director	UDisposition from Tender	−2,041 sh	$21.75	−$44.4K	0
2016-08-29	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−691 sh	$21.75	−$15K	0
2016-08-29	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−8,556 sh	$21.75	−$186K	0
2016-07-10	Sagent Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+591 sh	—	—	5,651
2016-07-10	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−591 sh	—	—	592
2016-06-07	SeaSpine Holdings CorpA Award	Director	AAward	+10K sh	—	—	10,010
2016-06-07	SeaSpine Holdings CorpStock Option (right to buy)A Award	Director	AAward	+18.1K sh	—	—	18,096
2016-02-25	Sagent Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+460 sh	—	—	4,830
2016-02-25	Sagent Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+230 sh	—	—	5,060
2016-02-25	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−460 sh	—	—	1,381
2016-02-25	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−230 sh	—	—	691
2016-02-22	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsA Award	Director	AAward	+8,556 sh	—	—	8,556
2016-02-22	Sagent Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+567 sh	—	—	4,370
2016-02-22	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−567 sh	—	—	0
2016-02-21	Sagent Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+760 sh	—	—	3,803
2016-02-21	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−760 sh	—	—	760
2016-02-18	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−930 sh	—	—	1,860
2016-02-18	Sagent Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+930 sh	—	—	3,043
2016-01-01	SeaSpine Holdings CorpStock Option (Right to Buy)A Award	Director	AAward	+5,015 sh	—	—	5,015
2015-08-01	SeaSpine Holdings CorpStock Option (Right to Buy)A Award	Director	AAward	+60.8K sh	—	—	60,811
2015-08-01	SeaSpine Holdings CorpStock Option (Right to Buy)A Award	Director	AAward	+59.9K sh	—	—	59,910
2015-07-10	Sagent Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+592 sh	—	—	2,113
2015-07-10	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−592 sh	—	—	1,183
2015-04-09	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsA Award	Director	AAward	+921 sh	—	—	921
2015-02-25	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsA Award	Director	AAward	+1,841 sh	—	—	1,841
2015-02-18	Sagent Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+930 sh	—	—	1,521
2015-02-18	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−930 sh	—	—	2,790
2014-07-10	Sagent Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+591 sh	—	—	591

Recent filings

Accepted (ET)
Jan 94
FEKETE MICHAEL0001637761-23-000042
SEC(opens sec.gov)
Jun 34
FEKETE MICHAEL0001637761-22-000094
SEC(opens sec.gov)
Sep 24
FEKETE MICHAEL0001637761-21-000175
SEC(opens sec.gov)
Jun 44
FEKETE MICHAEL0001637761-21-000128
SEC(opens sec.gov)
Jun 54
FEKETE MICHAEL0001637761-20-000074
SEC(opens sec.gov)
May 314
FEKETE MICHAEL0001637761-19-000082
SEC(opens sec.gov)
May 314
FEKETE MICHAEL0001637761-18-000094
SEC(opens sec.gov)
Nov 134
FEKETE MICHAEL0001637761-17-000169
SEC(opens sec.gov)
Jun 154
SeaSpine Holdings Corp0001637761-17-000123
SEC(opens sec.gov)
Mar 164
SeaSpine Holdings Corp0001637761-17-000065
SEC(opens sec.gov)
Aug 314
Sagent Pharmaceuticals, Inc.0000899243-16-028302
SEC(opens sec.gov)

Companies

Address

C/O SAGENT PHARMACEUTICALS, INC. 1901 NORTH ROSELLE ROAD, SUITE 700

SCHAUMBURG, IL, 60195